Determining the Safety and Efficacy of Prophylactic Defibrotide Administration in Children, Adolescents, and Young Adults with Sickle Cell Disease Following Myeloimmunoablative Conditioning (MAC) and Haploidentical Stem Cell Transplantation Utilizing CD34+ Selection and T-Cell (CD3) Addback (IND127812)
Author(s) -
Jordan Milner,
Justine Hung,
Janet Ayello,
Qiuhu Shi,
JulieAn Talano,
Theodore B. Moore,
Deborah Friedman,
Allen J. Dozor,
Liana Klejmont,
Harshini Mahanti,
Erin Morris,
Sandra Fabricatore,
Elizabeth Mintzer,
Allyson Flower,
Kenneth R. Cooke,
Mitchell S. Cairo
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.525
Subject(s) - medicine , defibrotide , population , transplantation , acute chest syndrome , incidence (geometry) , surgery , hematopoietic stem cell transplantation , pediatrics , disease , sickle cell anemia , environmental health , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom